Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms, Nerve Tissue 1Neoplasms 1Glioma 1Glioblastoma 1Brain Neoplasms 1

Interventions

pembrolizumab 222Carboplatin 216Cisplatin 204Paclitaxel 181Gemcitabine 148Docetaxel 125Capecitabine 114Dexamethasone 102Cyclophosphamide 102Pemetrexed 101Specimen Handling 99Magnetic Resonance Spectroscopy 97Oxaliplatin 95Radiotherapy 94Doxorubicin 90Fluorouracil 87Bevacizumab 82Nivolumab 73Leucovorin 72Rituximab 70durvalumab 66Vincristine 66Lenalidomide 64Etoposide 61atezolizumab 59Radiation 59Irinotecan 59130-nm albumin-bound paclitaxel 56Prednisone 55Letrozole 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Microbubbles × 1 year × Clear all
NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

NaviFUS Corporation

Phase 3 Recruiting
32 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡